Akiko Uenaka

2.2k citations
70 papers · 1.7k indexed · h-index 23
Topics
Immunotherapy and Immune Responses (47 papers)T-cell and B-cell Immunology (26 papers)Immune Cell Function and Interaction (23 papers)

In The Last Decade

Akiko Uenaka

69 papers receiving 1.7k citations

Peers

Akiko Uenaka
Comparison fields: 5 of 89
  • Immunology 1.1k
  • Molecular Biology 800
  • Oncology 429
  • Surgery 270
  • Radiology, Nuclear Medicine and Imaging 189
Replace Pei‐Xiang Xing with:
Pei‐Xiang Xing Australia
Liming Yang United States
Patricia Corthésy Switzerland
Mark DeBenedette United States
G. M. Fulop Canada
Florry A. Vyth‐Dreese Netherlands
Claude Gimmi United States
James G. McArthur United States
Megan Barnden Australia
Francis Brasseur Belgium
Akiko Uenaka relative to Pei‐Xiang Xing Australia Pei‐Xiang Xing's profile →
Citations per field
00.5×1.7×
Pei‐Xiang Xing · 1×
Citations per year

Countries citing papers authored by Akiko Uenaka

Since Specialization
Citations

This map shows the geographic impact of Akiko Uenaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akiko Uenaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akiko Uenaka more than expected).

Fields of papers citing papers by Akiko Uenaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akiko Uenaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akiko Uenaka. The network helps show where Akiko Uenaka may publish in the future.

Co-authorship network of co-authors of Akiko Uenaka

This figure shows the co-authorship network connecting the top 25 collaborators of Akiko Uenaka. A scholar is included among the top collaborators of Akiko Uenaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akiko Uenaka. Akiko Uenaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 20
2 48
3 2
4 66
5 58
6 18
7 4
8 2
9 6
10 5
11 22
12 1
13 54
14 4
15 1
16 19
17 12
18 194
19 37
20 69

About Akiko Uenaka

Akiko Uenaka is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Oncology, having authored 70 papers that have together received 1.7k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (47 papers), T-cell and B-cell Immunology (26 papers) and Immune Cell Function and Interaction (23 papers). The work is most often cited by research in Immunology (1.1k citations), Oncology (429 citations) and Molecular Biology (800 citations). Akiko Uenaka has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Eiichi Nakayama, Toshiro Ono, Hisashi Wada, Midori Isobe, Yuji Noguchi, Heiichiro Udono, Mikio Oka, Lloyd J. Old, Hiroshi Shiku and Tsukasa Seya. Their work appears in journals such as The Journal of Experimental Medicine, The Journal of Immunology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026